Search results
Stelara subcutaneous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
WebMD· 23 hours agoBruising, itching, pain, redness, swelling, or hardening of the skin at the injection site may occur. Injection site reactions usually go away after 1 or 2 days. Remember that this medication ...
My patients can’t afford two crucial medications, and Big Pharma should be held accountable
Colorado Newsline via Yahoo News· 3 days agoAs a physician, I am encouraged and impressed with the work that Colorado’s Prescription Drug...
The 3 Best Dow Stocks to Buy in June 2024
InvestorPlace· 2 days agoAs we enter June 2024, the Dow Jones Industrial Average continues to be a closely watched barometer of the U.S. stock market. In this article, we will...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 2 days agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
DePuy Synthes gets FDA nod for knee surgery robot By Investing.com
Investing.com· 1 day agoJohnson & Johnson's DePuy Synthes has obtained FDA 510(k) clearance for its VELYS™ Robotic-Assisted...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 5 days agoA biosimilar version of AbbVie’s blockbuster immunology medicine, Humira, called Simlandi, was...
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
InvestorPlace· 2 days agoFrom 1930 to 2023, 70% of dividend stocks in the top two quintiles outperformed the S&P 500 during...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 2 days agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year, Reuters reports ...